- Home
- IZM vs PASG Comparison
IZM vs PASG Comparison
Compare IZM & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- PASG
- Stock Information
- Founded
- IZM 2011
- PASG 2017
- Country
- IZM China
- PASG United States
- Employees
- IZM N/A
- PASG N/A
- Industry
- IZM Consumer Electronics/Video Chains
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- IZM Consumer Discretionary
- PASG Health Care
- Exchange
- IZM Nasdaq
- PASG Nasdaq
- Market Cap
- IZM 31.8M
- PASG 27.6M
- IPO Year
- IZM 2023
- PASG 2020
- Fundamental
- Price
- IZM $2.33
- PASG $8.07
- Analyst Decision
- IZM
- PASG Strong Buy
- Analyst Count
- IZM 0
- PASG 4
- Target Price
- IZM N/A
- PASG $59.25
- AVG Volume (30 Days)
- IZM 13.0K
- PASG 35.5K
- Earning Date
- IZM 10-24-2025
- PASG 11-12-2025
- Dividend Yield
- IZM N/A
- PASG N/A
- EPS Growth
- IZM N/A
- PASG N/A
- EPS
- IZM N/A
- PASG N/A
- Revenue
- IZM $180,553,977.00
- PASG N/A
- Revenue This Year
- IZM N/A
- PASG N/A
- Revenue Next Year
- IZM N/A
- PASG N/A
- P/E Ratio
- IZM N/A
- PASG N/A
- Revenue Growth
- IZM N/A
- PASG N/A
- 52 Week Low
- IZM $1.18
- PASG $5.12
- 52 Week High
- IZM $2.74
- PASG $26.60
- Technical
- Relative Strength Index (RSI)
- IZM 43.88
- PASG 54.77
- Support Level
- IZM $2.33
- PASG $8.02
- Resistance Level
- IZM $2.36
- PASG $8.92
- Average True Range (ATR)
- IZM 0.03
- PASG 0.48
- MACD
- IZM 0.00
- PASG -0.05
- Stochastic Oscillator
- IZM 40.00
- PASG 26.97
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.